Drug delivery through microneedles

R. Luttge

doi:10.1007/978-3-319-26920-7_10

Drug delivery through microneedles

R. Luttge

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

2 Citations (Scopus)

3 Downloads (Pure)

Abstract

Drug delivery through microneedles is a new form of a pharmaceutical dosage system. While single microneedles have been clinically applied already, the out-of-plane integration of a multitude of microneedles in a pharmaceutical patch is a disruptive technology. To take advantage of micro- and nanofluidics, such active patches utilize microneedle array (MNA) technology. MNAs are microsystems that adopt their technical uniqueness by the choice of a fabrication technology. MNAs can be made of solid, hollow, porous, or dissolvable materials in a cost-effective manner by the so-called MEMS technology. However, key to their success will be a proof-of-concept in the clinic, which must demonstrate that the intradermal (nano)release of drugs and vaccines serve an unmet medical need. In this chapter, we discuss recently established MNA platform technologies and by means of a case study we assess novel opportunities for MNAs in drug and vaccine delivery arising from this novel skin interface.

Original language	English
Title of host publication	Microsystems for Pharmatechnology : Manipulation of Fluids, Particles, Droplets, and Cells
Editors	A. Dietzel
Place of Publication	Dordrecht
Publisher	Springer
Pages	275-298
Number of pages	24
ISBN (Print)	9783319269207, 9783319269184
DOIs	https://doi.org/10.1007/978-3-319-26920-7_10
Publication status	Published - 1 Jan 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-26920-7_10

Cite this

@inbook{d344d8df02c94d15b151309401042bbd,

title = "Drug delivery through microneedles",

abstract = "Drug delivery through microneedles is a new form of a pharmaceutical dosage system. While single microneedles have been clinically applied already, the out-of-plane integration of a multitude of microneedles in a pharmaceutical patch is a disruptive technology. To take advantage of micro- and nanofluidics, such active patches utilize microneedle array (MNA) technology. MNAs are microsystems that adopt their technical uniqueness by the choice of a fabrication technology. MNAs can be made of solid, hollow, porous, or dissolvable materials in a cost-effective manner by the so-called MEMS technology. However, key to their success will be a proof-of-concept in the clinic, which must demonstrate that the intradermal (nano)release of drugs and vaccines serve an unmet medical need. In this chapter, we discuss recently established MNA platform technologies and by means of a case study we assess novel opportunities for MNAs in drug and vaccine delivery arising from this novel skin interface.",

author = "R. Luttge",

year = "2016",

month = jan,

day = "1",

doi = "10.1007/978-3-319-26920-7_10",

language = "English",

isbn = "9783319269207",

pages = "275--298",

editor = "A. Dietzel",

booktitle = "Microsystems for Pharmatechnology : Manipulation of Fluids, Particles, Droplets, and Cells",

publisher = "Springer",

address = "Germany",

}

TY - CHAP

T1 - Drug delivery through microneedles

AU - Luttge, R.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Drug delivery through microneedles is a new form of a pharmaceutical dosage system. While single microneedles have been clinically applied already, the out-of-plane integration of a multitude of microneedles in a pharmaceutical patch is a disruptive technology. To take advantage of micro- and nanofluidics, such active patches utilize microneedle array (MNA) technology. MNAs are microsystems that adopt their technical uniqueness by the choice of a fabrication technology. MNAs can be made of solid, hollow, porous, or dissolvable materials in a cost-effective manner by the so-called MEMS technology. However, key to their success will be a proof-of-concept in the clinic, which must demonstrate that the intradermal (nano)release of drugs and vaccines serve an unmet medical need. In this chapter, we discuss recently established MNA platform technologies and by means of a case study we assess novel opportunities for MNAs in drug and vaccine delivery arising from this novel skin interface.

AB - Drug delivery through microneedles is a new form of a pharmaceutical dosage system. While single microneedles have been clinically applied already, the out-of-plane integration of a multitude of microneedles in a pharmaceutical patch is a disruptive technology. To take advantage of micro- and nanofluidics, such active patches utilize microneedle array (MNA) technology. MNAs are microsystems that adopt their technical uniqueness by the choice of a fabrication technology. MNAs can be made of solid, hollow, porous, or dissolvable materials in a cost-effective manner by the so-called MEMS technology. However, key to their success will be a proof-of-concept in the clinic, which must demonstrate that the intradermal (nano)release of drugs and vaccines serve an unmet medical need. In this chapter, we discuss recently established MNA platform technologies and by means of a case study we assess novel opportunities for MNAs in drug and vaccine delivery arising from this novel skin interface.

UR - http://www.scopus.com/inward/record.url?scp=84960533324&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-26920-7_10

DO - 10.1007/978-3-319-26920-7_10

M3 - Chapter

AN - SCOPUS:84960533324

SN - 9783319269207

SN - 9783319269184

SP - 275

EP - 298

BT - Microsystems for Pharmatechnology : Manipulation of Fluids, Particles, Droplets, and Cells

A2 - Dietzel, A.

PB - Springer

CY - Dordrecht

ER -

Drug delivery through microneedles

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this